The FID test (Fungal Identification profile) indicates invasive fungal infections.
The test identifies colonies of fungus, mold, and yeast growing in the human body.
About six percent of the population is atopic (allergy-predisposed) with a respiratory allergy to airborne fungi. Systems other than respiratory may have other percentages.
Immunotherapy of allergy to fungi requires extracts that contain the relevant allergen (which can be difficult because there are frankly so many varietals. But Alternaria, Aspergillus, and Cladosporium, the most common, are easily available.
Mold litigation attorneys use the FID test to prove exposure.
If you’re in California, you might want to give us a call and see about getting an assessment from Byebyemold.